Astrazeneca (AZN) Gains from Sales and Divestitures (2016 - 2026)
Astrazeneca (AZN) reported Gains from Sales and Divestitures of -$94 million for Q2 2026, compared with -$21 million a year earlier.
Powered by 
Analysis
Astrazeneca (AZN) Gains from Sales and Divestitures (2016 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Astrazeneca's Gains from Sales and Divestitures came in at -$209 million; for FY2025, it was -$168 million.
- By year, Gains from Sales and Divestitures came in at -$64 million in FY2024, -$251 million in FY2023, -$104 million in FY2022 and -$513 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Gains from Sales and Divestitures since Q4 2023.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$34 million (Q1 2026), -$50 million (Q4 2025) and -$31 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -94.00 Mn |
| Mar 31, 2026 | -34.00 Mn |
| Dec 31, 2025 | -50.00 Mn |
| Sep 30, 2025 | -31.00 Mn |
| Jun 30, 2025 | -21.00 Mn |
| Mar 31, 2025 | -66.00 Mn |
| Dec 31, 2024 | -64.00 Mn |
| Sep 30, 2024 | -13.00 Mn |
| Dec 31, 2023 | -251.00 Mn |
| Mar 31, 2023 | -249.00 Mn |
| Jun 30, 2022 | -71.00 Mn |
| Mar 31, 2022 | -10.00 Mn |
| Dec 31, 2021 | -371.00 Mn |
| Sep 30, 2021 | -17.00 Mn |
| Jun 30, 2021 | -44.00 Mn |
| Mar 31, 2021 | -310.00 Mn |
| Dec 31, 2020 | -1.03 Bn |
| Sep 30, 2020 | -124.00 Mn |
| Jun 30, 2020 | -53.00 Mn |
| Mar 31, 2020 | -358.00 Mn |
API Access
Astrazeneca Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();